0001656472-15-000001.txt : 20151023
0001656472-15-000001.hdr.sgml : 20151023
20151023132918
ACCESSION NUMBER: 0001656472-15-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20151023
DATE AS OF CHANGE: 20151023
EFFECTIVENESS DATE: 20151023
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmaCan Capital Corp.
CENTRAL INDEX KEY: 0001656472
IRS NUMBER: 000000000
STATE OF INCORPORATION: A6
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-249981
FILM NUMBER: 151172479
BUSINESS ADDRESS:
STREET 1: 76 STAFFORD STREET, SUITE 302
CITY: TORONTO
STATE: A6
ZIP: M6J 2S1
BUSINESS PHONE: (416) 504-0004
MAIL ADDRESS:
STREET 1: 76 STAFFORD STREET, SUITE 302
CITY: TORONTO
STATE: A6
ZIP: M6J 2S1
D
1
primary_doc.xml
X0707
D
LIVE
0001656472
PharmaCan Capital Corp.
76 STAFFORD STREET, SUITE 302
TORONTO
A6
ONTARIO, CANADA
M6J 2S1
(416) 504-0004
ONTARIO, CANADA
2339498 Ontario Inc.
Searchtech Ventures Inc.
None
Corporation
true
2012
Paul
Rosen
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Executive Officer
Director
Lorne
Gertner
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Director
Glen
Huber
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Executive Officer
Director
Alan
Friedman
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Director
Ryan
Roebuck
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Director
Michael
Howard
Krestell
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Director
Steven
Isenberg
76 Stafford Street, Suite 302
Toronto
A6
ONTARIO, CANADA
M6J 2S1
Director
Investing
Decline to Disclose
- 06b
false
2015-10-08
true
true
true
true
true
Units each comprised of one common share and one common share purchase warrant exercisable at Cdn$0.31 per warrant share for 5 years
false
0
3993807
1147800
2846007
$2,080,807 of the total amount remaining to be sold represents the purchase price of common shares purchasable upon exercise of warrants sold in the offering. US dollar amounts were calculated based on a 0.7652 exchange rate for one Canadian dollar.
false
6
0
0
0
false
PharmaCan Capital Corp.
/s/ Paul Rosen
Paul Rosen
President and Chief Executive Officer
2015-10-23